Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 63, 2008 - Issue 6
63
Views
6
CrossRef citations to date
0
Altmetric
Case Report

PELVIC INFLAMMATORY DISEASE DUE TO STREPTOCOCCUS PNEUMONIAE: A USUAL PATHOGEN AT AN UNUSUAL PLACE

, , , , , & show all
Pages 398-401 | Published online: 09 Jan 2014

REFERENCES

  • Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin lnf Dis 1992; 14: 801–9.
  • Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE. Pel-vic inflammatory disease and fertility. Sex transm Dis 1992; 19: 185–92.
  • Ness RB, Hillier SL, Richter HE, et al. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 2002; 100: 765–72.
  • Soper DE, Brockwell NJ, Dalton HP, Johnson D. Observations concerning the microbial etiology of acute salpingitis. Am] Obstet Gynecol 1994; 170: 1008–17.
  • Bartlett JG, Onderdonk AB, Drude E, et al. Quantitative bacteri-ology of the vaginal flora.] Infect Dis 1977; 136:217–77.
  • Westh H, Skibsted L, Korner B. Streptococcus pneumoniae infec-tions of the female genital tract and in the newborn child. Rev Infect Dis 1990; 12: 416–22.
  • Ekwempu CC, Lawande RV, Egler Li. Microbial flora of the lower genital tract of women in labour in Zaria, Nigeria.] Clin Pathol 1981; 34:82–3.
  • McDonald LC, Bryant K, Snyder J. Peripartum transmission of penicillin-resistant Streptococcus pneu monia e. J Clin Microbiol 2003; 41:2258–60.
  • Marazzo JM, Koutsky LA, Eschenbach DA, Agnew K, Stine K, Hillier SL. Characterization of vaginal flora and bacterial vagino-sis in women who have sex with women. J Inf Dis 2002; 185: 1307–13.
  • Schwebke JR, Richey CM, Weis HL. Correlation of behaviours with microbiological changes in vaginal flora.] Infect Dis 1999; 180: 1632–6.
  • Bucher A, Muller F. Spectrum of abdominal and pelvic infections caused by pneumococci in previously healthy adult women. Eur J Clin Microbiol Infect Dis 2002; 21: 474–7.
  • Hemsley C, Eykyn Si. Pneumococcal peritonitis in previously healthy adults: case report and review. Clin Inf Dis 1998; 27: 376–9.
  • Lamb EK, Anasti JN, Leonetti HB. Group A Streptococcus causing PI D from an initial pharyngeal infection. A case report.JReprod Med 1999; 44:639–41.
  • Heinonen PK, Miettinen A. Laparoscopic study on the microbiol-ogy and severity of acute pelvic inflammatory disease. Eur J Obstet Gynecol Reprod Biol 1994; 52:85–9.
  • Smego RA, Foglia G. Actinomycosis. Clin Infect Dis 1998; 26: 1255–63.
  • Westhoff C. IUDs and colonization or infection with Actinomy-ces. Contraception 2007; 75: S48–550.
  • Nielsen KR, Ejlertsen T, El-Batran S, Prag J. A five-year survey of pneumococcal peritonitis in two Danish counties - incidence, diagnosis and clinical entities. Clin Microbiol Infect 2003; 9:738–40.
  • Goldman JA, Yeshaya A, Peleg D, Dekel A, Dicker D. Severe pneu-mococcal peritonitis complicating IUD: case report and review of the literature. Obset Gynecol Surv 1986; 41: 672–4.
  • Rudensky B, Abramowitz H, Yinnon AM, Alberton J. Intrauterine device as source of pneumococcal intra-abdominal infection and small-bowel obstruction. EurJ Clin Microbiol Infect Dis 2004; 23: 576–7.
  • Mohllajee AP, Curtis KM, Peterson HB. Does insertion of an in-trauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A system-atic review. Contraception 2006; 73: 145–53.
  • Shelton JD. Risk of clinical pelvic inflammatory disease attribut-able to an intrauterine device. Lancet 2001; 357: 443.
  • Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauter-ine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339: 785–8.
  • Viberga I, and V, Lazdane G. Characteristics of women at low risk of STI presenting with pelvic inflammatory disease. EurJ Contracept Reprod Health Care 2006; 11:60–8.
  • Viberga I, and V, Lazdane G, Kroica J, Berglund L, Olofsson S. Microbiology profile in women with pelvic inflammatory disease in relation to IUD use. Infect Dis Obstet Gynecol 2005; 13:183–90.
  • Pal Z, Urban E, Dosa E, Pal A, Nagy E. Biofilm formation on in-trauterine devices in relation to duration of use.] Med Micro-biol 2005; 54:1199–203.
  • The RoyalWomen's Hospital Clinical Practice Guidelines: http://rch.org.au/rwhcpg.
  • Walker CK, Wiesenfield HC. Antibiotic therapy for acute pelvic inflammatory disease:The 2006 centers for disease control and prevention sexually transmitted disease treatment guidelines. Clin lnf Dis 2007; 44: S111–S22.
  • http://www.iph.fgov.be/epidemio/epinl/plabnl/plabannE/06030nr.pdf.
  • Soderberg G, Lindgren S. Influence of an intrauterine device on the course of an acute salpingitis. Contraception 1981;24: 137–4.
  • Altunyurt S, Demir N, Posaci C. A randomized controlled trial of coil removal prior to treatment of pelvic inflammatory disease. EurJ Obstet Gynecol Reprod Biol 2003; 107: 81–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.